Overview
Status
Active
Registry date
2024-08-09
Share capital
100,000.00 PLN
Registered address
Warszawa, Poland
Website
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Dorota Agata Rokicka – President of the Management Board
Manner of representation
The company is represented by the management board. Declarations on behalf of the company may be submitted by: 1. in the case of a one-person management board–the sole member of the management board independently; 2. in the case of a multi-member management board: a) the President of the Management Board or the Vice-President independently; b) two members of the management board acting jointly or one member of the management board jointly with a commercial proxy.
Supervisory board
Grzegorz Cezary Surdyn – Supervisory Board Member
Fryderyk Robert Gawron – Supervisory Board Member
Julia Karolina Surdyn – Supervisory Board Member
Ownership
| Owner | Share value | Stake |
|---|---|---|
Dorota Agata Rokickaage 64 | $27,012.43 | 100% |
Beneficial owners
No beneficial owners recorded for the company Invigen.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiResearch institute | $355,967,543.57 | cskmswia.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-29 | Address change (Ul. Rtm. Witolda Pileckiego 59/3, 02-781, Warszawa → Warszawa) | |
| 2024-08-09 | Entered in the register |
FAQ
The main business activity of Invigen focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 9, 2024.
The headquarters is located at: Warszawa.
The share capital of the company is PLN 100,000 (approx. $27,012).
Last updated: 2026-04-29